181 Evaluation of the usefulness of dose calculation algorithms in radiotherapy planning  by Kiełtyka, B. et al.
S88  ICTR-PHE 2016 
 
 
References: 
[1] Chaudhary et al., Int J. Radiation Oncol Biol Phys, 2014 
90:27-35 
[2] Chaudhary et al., Int J. Radiation Oncol Biol Phys, 2015 
Jul 29. pii: S0360-3016(15)03070-9. doi: 
10.1016/j.ijrobp.2015.07.2279. 
 
180 
Quantum dots imaging tests on SPAD for nanodosimetric 
applications 
L. Pancheri1,2, A. Quaranta1,2, G. F. Dalla Betta1,2, A. 
Ficorella1, M. Dalla Palma1,3 
1 University of Trento, Department of Industrial Engineering, 
via Sommarive 9, I-38123 Povo, Trento, Italy. 
2 INFN, TIFPA, via Sommarive 14, I-38123 Povo, Trento, Italy. 
3 INFN, Laboratori Nazionali di Legnaro, Viale dell’Università, 
2, I-35020 Legnaro (Padova), Italy. 
 
Purpose of this work: Nowadays it is well assessed that the 
particle track structure plays a key role in the damage of 
living cells1. Therefore, the quantification of the dose within 
nanometric volumes is of paramount importance for 
characterizing the effectiveness of cancer treatments with 
ion beams. There are currently several facilities suitable for 
the detailed on-line analysis of the number of ionizations left 
by an impinging ions into nanometer equivalent gas 
volumes.2,3 Nonetheless, the realization of a portable system 
for nanodosimetry  quantification would be extremely useful 
for the dose control in treatment plants. In this work we 
propose the use of Single Photon Avalanche Diode (SPAD) 
arrays for the luminescence imaging of quantum dots (QDs) 
structures.4 In particular, the analysis of QD layers will be 
performed before and after ion irradiation in order to study 
how the released dose affects the optical properties of the 
system. 
Materials and methods: The luminescence of CdSe/ZnS QD 
layers is excited with a pulsed LED (475 nm central 
wavelength and 20 ns pulse width).5 The luminescence light 
is collected with a high-numerical aperture optics and 
delivered to the detector through an optical filter to 
eliminate the residual scattered excitation light (Figure 1a). 
A SPAD pixel array6 is placed in the focal plane to collect the 
fluorescence map of the sample under analysis. The light 
signal is collected in time-gated mode in order to measure 
the QD lifetime before and after irradiation (Figure 1b). 
Moreover, time-gated detection can be used as a time-
domain excitation filtering technique, thus simplifying the 
design of a portable and compact nanodosimeter. 
Results: The luminescence intensity and lifetime of QD 
irradiated with different fluencies of 2.0 MeV protons and X-
rays will be studied and compared with non-irradiated 
samples. The changes in light yield and lifetime will be 
correlated to the damage released by the impinging radiation 
through Monte Carlo calculations. 
Conclusions: Although SPAD arrays have already been 
employed in the past for the sensing of QD luminescence, 
this is the first time that QD lifetime measurements is 
proposed as a probing tool applied to nanodosimetry. This 
preliminary study will give an experimental confirmation on 
the validity of the idea.  
 
 
 
Figure 1. (a) Simplified system diagram (b) Illustration of 
time gated detection principle 
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Purpose: One of the main goals of radiotherapy is to achieve 
tumor control and minimize probability of normal–tissue 
complications. For this reason radiation oncology requires 
high accuracy, which implies no more than 2 – 3% uncertainty 
levels in the treatment planning calculations [1]. That is 
challenging, when heterogeneous tissues such as lungs and 
bones are involved [2,3]. To verify the accuracy of the dose 
calculation algorithms numerous approaches might be 
performed. The most common are point dose, one-
dimensional profile and two-dimensional isodose line 
comparison with experimental measurements [3]. 
Materials/Methods: In presented study, results of transport 
modeling and the deposited spatial distribution of the dose, 
obtained by Anisotropic Analytical Algorithm (AAA) and Pencil 
Beam Convolution algorithm (PBC), were compared to 
measurements recorded during the experiment. To achieve 
meaningful conclusions, three parameters: dose difference 
(DD), distance to agreement (DTA) and gamma parameter (γ) 
were taken into consideration and examined. The irradiation 
was performed using CIRS anthropomorphic phantom. For 
dose detection gafchromic EBT films were used and scanned 
after exposure using Epson Scanner. Measured and planned 
dose distributions were analyzed via FilmQA software.  
Results and Conclusions: Preliminary results showed that the 
AAA, with its complex accounting of heterogeneities, 
provides more accurate dose calculation within an area of a 
high density gradient, than PBC does. The level of the data 
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accuracy derived from the experiment was: DD (5%) – 83.4% 
and 68% pixels passing, DTA (3mm) – 99.0% and 96,7%, gamma 
parameter (for DD (3%), DTA (3mm)) – 90% and 75,5% 
respectively for AAA and PBC algorithms. The comparison 
between studied parameters DD, DTA and γ for both 
algorithms implicated AAA as an appropriate approach 
in radiotherapy treatment planning. 
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The effect of nuclear fragmentation in the passage of 180MeV 
protons through the human body tissue is discussed. Prostate 
cancer protontherapy with these intermediate-energy 
protons is discussed in light of model calculation. 
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Rationale: An alternative approach for the improvement of 
radiotherapy consists in increasing differentially the radiation 
dose between tumors and healthy tissues using nanoparticles 
(NPs) that have been beforehand internalized into the tumor. 
These high-Z NPs can be photo-activated by monochromatic 
synchrotron X-rays, leading to a local dose enhancement 
delivered to the neighboring tumor cells[1]. This 
enhancement is due to secondary and Auger electrons 
expelled from the NPs by the radiations. In order to carry the 
NPs into the tumor center, macrophages are currently under 
study for their phagocytosis and diapedesis abilities[2] (cf. 
Figure adapted from [3] and [4]). In this study we 
characterized J774A.1 macrophages’ internalization kinetics 
and subcellular distribution of iron NPs and compared them 
to the internalization abilities of the F98 glioblastoma cell 
line. 
Materials and Methods: Three aspects of internalization were 
examined: first, the location of internalized NPs in J774A.1 
macrophages and F98 glioblastoma cells following a 24h 
incubation with iron NPs (0.3 mg/mL in the cell culture 
medium) was determined by optical microscopy after cell 
slicing. Subsequently, the iron intake after a 24h incubation 
with NPs (0.3 mg/mL and 0.06 mg/mL in the cell culture 
medium) was characterized for the two types of cells using 
ICP-MS. Finally, the internalization dynamics were studied by 
live phase-contrast microscopy imagining for 11 hours and by 
absorbance measurements for 24 hours using a plate reader. 
Results: F98 tumor cells and J774A.1 macrophages are both 
able to endocytose NPs: we measured ~61±10 pg of 
internalized iron per macrophage compared with ~33±5 pg 
per F98 cell (initial iron concentration: 0.3 mg/mL in culture 
medium). F98 internalizing NPs for 10 hours showed stress 
signs during the first minutes after the NPs injection, but 
behaved like F98 control cells during the rest of the 
experiment. Finally, we determined that the internalization 
kinetics for J774A.1 had a typical saturation time of one 
hour. 
Conclusion: Macrophages seem to be promising vectors for 
NPs, being able to endocytose and retain in their cytoplasm 
larger quantities of NPs than tumor cells. Our following 
studies will attempt to shed light on their other potential 
abilities as “Trojan Horses”. 
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